Galderma Group AG
GALD
Rangering i aksjer
#459
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Aksjekurs
$224.81
Markedsverdi
$52.42B
Endring (1 dag)
6.31%
Endring (1 år)
31.28%
Land
CH
Handel Galderma Group AG (GALD)
Kategori
Healthcare
Utbytteavkastning for Galderma Group AG (GALD)
Galderma Group AG (aksjesymbol: GALD) sin utbytteavkastning (TTM) per 2024-12-31 er: 0.00%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.02%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.02%
Utbytteavkastning for Galderma Group AG (GALD) fra 2021 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
| År | Utbytteavkastning | Endre |
|---|---|---|
| 2026 (TTM) | 0.19% | 137.50% |
| 2025 | 0.08% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
| Selskap | Utbytteavkastning | Land |
|---|---|---|
| 1.63% |
DE
|
|
| 1.50% |
DE
|
|
| 3.18% |
JP
|
|
| 0.91% |
IN
|
|
| 0.43% |
CN
|
